With so many side effects from psychiatric medications, why aren’t more physicians using pharmacogenetics?
In the U.S. we spend billions of dollars managing the side effects of psychiatric medications.
World wide over 100 million people take psychiatric medications. In 2004, the FDA finally ordered a “black box” label on all antidepressants to warn of psychiatric drugs’ increasing suicide risk in children and adolescents. Being an adult, however, doesn’t guarantee safety. In 2006, the FDA increased the age to include young adults up to age of 25. So why aren’t we doing more about it to prevent this from happening?
Pharmacogenetics aligns current and future medications with each persons unique genetic profile. So if a test can scientifically tell you what medications can give you therapy, which ones can’t, and which drugs can have potential drug on drug interactions based on your genetic make-up.
In the U.S. it is estimated we spend billions of dollars annually managing the side effects from psychiatric medications. Now there is a tool available that can improve patient outcomes and help physicians monitor the side effects in the field of psychiatry and it is simple to use.
Pharmacogenetics is now being used across the country to help guide healthcare professionals with proper prescribing. When used correctly, it can save money and the patient can be spared a lot of undue stress.
For more information, contact PGx Medical at info@pgxmed.com or 405-509-5112.
source: globalhealingcenter.om